Pulse Biosciences (PLSE) Research & Development (2015 - 2025)

Pulse Biosciences' Research & Development history runs 11 years deep, the most recent figure standing at $11.4 million for Q3 2025.

• On a quarterly basis, Research & Development rose 47.9% year-over-year to $11.4 million in Q3 2025; TTM through Sep 2025 was $44.5 million, a 50.84% increase from a year earlier, with the FY2024 full-year figure at $32.3 million, up 16.33% from the prior year.
• Research & Development eased to $11.4 million in Q3 2025 per PLSE's latest filing, from $12.1 million in the prior quarter.
• Across five years, Research & Development topped out at $12.1 million in Q2 2025 and bottomed at $4.1 million in Q4 2022.
• The 5-year median for Research & Development is $7.2 million (2024), against an average of $7.5 million.
• Across the five-year window, Research & Development plunged 30.08% in 2022 and jumped 90.45% in 2023, its largest moves.
• Year by year, Research & Development stood at $5.7 million in 2021, then dropped by 27.62% to $4.1 million in 2022, then surged by 90.45% to $7.8 million in 2023, then surged by 36.71% to $10.7 million in 2024, then climbed by 6.86% to $11.4 million in 2025.
• Per Business Quant, the three latest PLSE Research & Development figures stand at $11.4 million (Q3 2025), $12.1 million (Q2 2025), and $10.3 million (Q1 2025).